Article
Binding of Specific S100 Proteins Inhibits Activity of Tumor Necrosis Factor
2022-11-16
Abstract excerpt
Tumor necrosis factor (TNF) inhibitors (anti-TNFs) represent a cornerstone of the treatment of various immune-mediated inflammatory diseases and are among the most commercially successful therapeutic agents. Knowledge of TNF binding partners is critical for identification of the factors able to affect clinical efficacy of the anti-TNFs. Here we report that among eighteen representatives of the multifunctional S100...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0caeb235-7999-501c-a0a9-446ca4c9106c
- DOI
- 10.20944/preprints202211.0313.v1
